Poseida Therapeutics Investor Relations Material
Latest events
Status Update
Poseida Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Poseida Therapeutics Inc
Access all reports
Poseida Therapeutics, Inc. (PSTX) is a clinical-stage biopharmaceutical company that specializes in developing innovative cell and gene therapies. These therapies aim to provide cures for cancers and genetic diseases by leveraging non-viral gene engineering technologies. Poseida's product pipeline includes both autologous and allogeneic chimeric antigen receptor T cell (CAR-T) therapies, which are at the forefront of treating hematological malignancies and solid tumors. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for Poseida Therapeutics Inc
Status Update
Poseida Therapeutics Inc
Status Update
Poseida Therapeutics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PSTX
Country
🇺🇸 United States